Confirmation of Rescission of Note Amendments between 180 Life Sciences Subsidiaries and Sir Marc Feldmann

Contract Categories: Business Finance › Modification Agreements
Summary

This agreement is between 180 Life Corp., CannBioRex Pharma Ltd., CannBioRex Pharma Corp. (subsidiaries of 180 Life Sciences Corp.), and Sir Marc Feldmann. It confirms that certain amendments to loan agreements made on November 27, 2020, and February 10, 2021, were entered into by mistake and do not reflect the parties' intentions. The parties agree to rescind and terminate these amendments as if they never existed, effective as of the original amendment dates listed in the attached exhibit.

Read More Arrow
EX-10.15 2 f10q0321ex10-15_180life.htm SIR MARC FELDMANN CONFIRMATION OF RESCISSION OF NOTE AMENDMENTS EFFECTIVE FEBRUARY 25, 2021

Exhibit 10.15

 

CONFIRMATION OF RESCISSION OF NOTE AMENDMENTS

 

On November 27, 2020 and February 10, 2021, 180 Life Corp., CannBioRex Pharma Ltd. and CannBioRex Pharma Corp., each director or indirect subsidiaries of 180 Life Sciences Corp., a Delaware corporation (the “Companies”), entered into 18 Amendment to Loan Agreements with Sir Marc Feldmann, as more fully described in Exhibit A (collectively, the “Note Amendments”).

 

The Note Amendments were entered into in error, and by their execution of this Confirmation of Rescission of Note Amendments below, Sir Marc Feldmann and the Companies, agree, confirm and acknowledge that:

 

●The Note Amendments were entered into error and did not reflect the agreement of the parties thereto;

 

●Such Note Amendments are rescinded and terminated, effective as of the applicable dates set forth under “Date of Amendment” on Exhibit A (the “Effective Date”, as applicable); and

 

●The effect of this Confirmation of Rescission of Note Amendments shall be as if such Note Amendments were never entered into by the parties, never effective and never binding, effective as of the Effective Date (as applicable).

 

    180 Life Corp.
       
    By: /s/ James Woody 
       
    Printed Name: James Woody
       
    Its: CEO 180 Life Sciences
       
    CannBioRex Pharma Ltd.
       
    By: /s/ Ozan Pamir
       
    Printed Name: Ozan Pamir
       
    Its: CFO 
       
    CannBioRex Pharma Corp.
       
    By: /s/ Ozan Pamir
       
    Printed Name:  Ozan Pamir
       
    Its: CFO
 /s/ Marc Feldmann    
Sir Marc Feldmann    

 

 

 

 

EXHIBIT A

 

Number  Noteholder Name  Date of
Amendment		  Borrower  Currency  Amount   Date of Original Note
1  Sir Marc Feldmann  2/10/2021  180 Life Corp.  GBP   60,000   10/20/2019
2  Sir Marc Feldmann  2/10/2021   CannBioRex Pharma Ltd.  GBP   5,198.18   2/28/2019
3  Sir Marc Feldmann  2/10/2021  180 Life Corp.  USD   40,000   10/29/2019
4  Sir Marc Feldmann  2/10/2021  180 Life Corp.  USD   10,000   10/29/2019
5  Sir Marc Feldmann  2/10/2021   CannBioRex Pharma Ltd.  GBP   15,029.78   11/27/2019
6  Sir Marc Feldmann  2/10/2021  CannBioRex Pharma Corp.  CAD   10,000   12/11/2019
7  Sir Marc Feldmann  2/10/2021  180 Life Corp.  USD   137,381   1/20/2020
8  Sir Marc Feldmann  2/10/2021   CannBioRex Pharma Ltd.  GBP   5,193.18   1/30/2020
9  Sir Marc Feldmann  2/10/2021   CannBioRex Pharma Ltd.  GBP   14,111.43   2/28/2020
10  Sir Marc Feldmann  2/10/2021  180 Life Corp.  USD   1,871.75   4/2/2020
11  Sir Marc Feldmann  2/10/2021  180 Life Corp.  USD   1,563.75   4/2/2020
12  Sir Marc Feldmann  2/10/2021  180 Life Corp.  USD   12,905   4/13/2020
13  Sir Marc Feldmann  2/10/2021  180 Life Corp.  USD   7,889.75   5/30/2020
14  Sir Marc Feldmann  11/27/2020   CannBioRex Pharma Ltd.  GBP   6,712.31   8/26/2020
15  Sir Marc Feldmann  2/10/2021  181 Life Corp.  GBP   5,833.33   4/28/2020
16  Sir Marc Feldmann  2/10/2021  180 Life Corp.  GBP   5,193.18   10/30/2019
17  Sir Marc Feldmann  2/10/2021  180 Life Corp.  USD   1,961   5/19/2020
18  Sir Marc Feldmann  2/10/2021  180 Life Corp.  GBP   5,833.33   5/29/2020